Originally published by our sister publication Pain Medicine News
A recent systematic review found that opioid misuse in cancer patients is highly prevalent, with rates ranging from 5.7% to 84.0%. The prevalence of opioid misuse risk varied between 2.4% and 35.4%, with a pooled prevalence of 12.3%.
The observed disparities in opioid misuse percentages underscore the need for more studies using standardized definitions, validated assessment tools and consistent research methods to accurately